SCHEMBL6890789

SCHEMBL6890789

CC(=O)CC(c1ccccc1)(c1c(O)c2ccccc2oc1=O)[N+](=O)[O-]

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.52
NR1I2 O75469 1/20 0.52
NR3C1 P04150 1/20 0.52
ADRA1A P35348 1/20 0.52
KCNH2 Q12809 1/20 0.52
CA12 O43570 1/20 0.48
CA9 Q16790 1/20 0.48
ALDH1A1 P00352 4/20 0.46
KDM4E B2RXH2 4/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
VKORC1 Q9BQB6 3/20 0.46
ALB P02768 2/20 0.46
PCSK7 Q16549 1/20 0.46
HSD17B10 Q99714 1/20 0.46
MAPT P10636 2/20 0.43
LMNA P02545 2/20 0.43
POLB P06746 1/20 0.43
RECQL P46063 1/20 0.43
GALK1 P51570 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15514111 0.80 ALDH1A1 (0.51) CYP2C9CA12CA9ALDH1A1KDM4E
SCHEMBL3778823 0.80 ALDH1A1 (0.51) CYP2C9CA12CA9ALDH1A1KDM4E
SCHEMBL7351830 0.79 ALDH1A1 (0.50) CYP2C9NR1I2NR3C1ADRA1AKCNH2
SCHEMBL3048772 0.76 ALDH1A1 (0.46) CYP2C9CA12CA9ALDH1A1KDM4E
SCHEMBL2358729 0.74 LMNA (0.48) CYP2C9CA12CA9ALDH1A1KDM4E
SCHEMBL7354341 0.73 KDM4E (0.55) CYP2C9CA12CA9ALDH1A1KDM4E
SCHEMBL9286035 0.72 NQO1 (0.53) CYP2C9CA12CA9ALDH1A1KDM4E
SCHEMBL1649890 0.72 NQO1 (0.50) CYP2C9CA12CA9ALDH1A1KDM4E
SCHEMBL5103338 0.71 NQO1 (0.52) CYP2C9CA12CA9ALDH1A1KDM4E
SCHEMBL12091846 0.70 CA12 (0.49) CYP2C9CA12CA9ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040084867-A1 Individualization of therapy with anticoagulants XANTHUS LIFE SCIENCES, INC. 2004-05-06 US disclosed
WO-2004003550-A2 INDIVIDUALIZATION OF THERAPY WITH ANTICOAGULANTS XANTHUS LIFE SCIENCES, INC. (US) 2004-01-08 WO disclosed